Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
14 août 2024 09h05 HE
|
Elevai Labs Inc.
Elevai Labs Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update
Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD
30 juil. 2024 09h00 HE
|
Elevai Labs Inc.
Elevai Labs Inc. Subsidiary, Elevai Biosciences, Continues to Advance its Scientific Advisory Board with the Appointment of Orian Shirihai, MD, PhD
Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line
28 juin 2024 09h00 HE
|
Elevai Labs Inc.
Elevai Labs Inc. Subsidiary, Elevai Skincare, Announces The Elevai S-Series Hair and Scalp Care Product Line
Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024
26 juin 2024 09h00 HE
|
Elevai Labs Inc.
Elevai Labs Inc. Subsidiary, Elevai Skincare to Debut Upcoming New Product Line at The Aesthetic Show 2024
Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
14 juin 2024 09h00 HE
|
Elevai Labs Inc.
Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm
29 mai 2024 09h00 HE
|
Elevai Labs Inc.
Elevai Labs Subsidiary, Elevai Skincare, to Present at the Beauty Through Science Conference in Stockholm
Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference
22 mai 2024 16h15 HE
|
Elevai Labs Inc.
Elevai Labs Inc Subsidiary, Elevai Biosciences, to Present at the UCLA LA-BEST 2024 Conference
Elevai Labs Inc. Reports First Quarter 2024 Financial Results
15 mai 2024 16h30 HE
|
Elevai Labs Inc.
Elevai Labs Inc. Reports First Quarter 2024 Financial Results
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
02 mai 2024 08h30 HE
|
Elevai Labs Inc.
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare
01 mai 2024 16h00 HE
|
Elevai Labs Inc.
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare